The regulatory landscape governing the approval of generic topical products is changing on both sides of the Atlantic, and the senior vice president of business development for MedPharm talks about what this means in terms of in-vitro release testing and in-vitro permeation testing models and other issues
.. [
more ]
As he retires from teaching at the university level (though he's not yet from retired from life sciences), columnist Peter Kissinger reflects on the past five decades of experiences and his observations of our industry.. [
more ]
by Peter T. Kissinger
Life sciences and pharma know-how have achieved a lot, but expecting drug discovery and development to be like construction and manufacturing is asking a bit much.. [
more ]
